CEPHALON FINLAND A/S: Financial statements 2020
CVR: 29245037
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
CEPHALON FINLAND A/S (CVR 29245037) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 4,446,499 and a net result of DKK 972,917 compared with DKK 719,597 the year before. That is an increase of 18.4% compared with the year before. Equity in the 2020 report amounted to DKK 5,578,895. The solvency ratio was 48.8%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 4,446,499
- Profit/Loss
- DKK 972,917
- Equity
- DKK 5,578,895
- Total Assets
- DKK 11,421,339
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 4.4M | 973K | 5.6M | 5 |
| 2019 | - | 3.8M | 720K | 5.3M | 3 |
| 2018 | - | 3.2M | 267K | 4.8M | 3 |
| 2017 | - | 4.2M | 836K | 4.9M | 6 |
| 2016 | - | 4.4M | -893K | 4M | - |
Official annual report
How creditworthy is CEPHALON FINLAND A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CEPHALON FINLAND A/S has published its annual report for 2019. Gross profit came to DKK 3,755,533, and the net result was DKK 719,597.
About CEPHALON FINLAND A/S
CEPHALON FINLAND A/S is a Danish company of the type Aktieselskab based in Nørresundby, founded in 2006. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Rolf Nejsum. The board consists of Bjørn Helmer Johnsen (chair), Rolf Nejsum and Vesa Antero Toropainen. The company is owned by Scanmed AS Norway. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK 7,078,554 and a net result of DKK 2,059,375 compared with DKK 296,806 the year before. Equity in the 2025 report amounted to DKK 7,193,391.
